Company intelligence / Profile preview

International Patent Reviews

Dallas, Texas, United States

Ownership: Private
Development stage: Other

Overview

International Patent Reviews is a private U.S. company focused on pharmaceutical patent analysis rather than drug discovery or development. The firm reviews branded-drug patent estates, prepares analyses intended to challenge weak or overly broad pharmaceutical patents, and supports remedies including inter partes review and related legal or public-interest actions. Its positioning is healthcare-adjacent: the company frames its work around improving competition in prescription drugs and lowering costs for patients, providers, and health systems. Publicly available materials indicate it has published studies on patents covering medicines such as dolutegravir and LEVULAN KERASTICK.

Industry: Consulting

Partnerships

Complete Healthcare Management

Beyond the preview

Go deeper on International Patent Reviews.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on International Patent Reviews.

Explore the full profile